From pandemic influenza to novel coronaviruses: emerging infectious diseases of the 21st century.

From pandemic influenza to novel coronaviruses: emerging infectious diseases of the 21st century.

Publication date: Apr 01, 2026

Emerging infectious diseases have risen significantly in the twenty-first century as ecological disruption, climate change, expanding human-animal interfaces, and global mobility intensify opportunities for pathogen transmission. This review synthesizes historical and contemporary evidence across viral, bacterial, fungal, and parasitic threats to characterize how diverse pathogens emerge and spread. Foundational events such as the 1918 influenza pandemic, mid-century influenza pandemics, the emergence of HIV/AIDS, and the eradication of smallpox provide context for understanding modern disease dynamics. In recent decades, coronaviruses including SARS, MERS, and SARS-CoV-2, pandemic H1N1, avian influenza subtypes, and major arboviruses such as dengue, chikungunya, Zika, West Nile virus, and yellow fever have demonstrated the rapidity with which zoonotic pathogens can disseminate globally. Viral hemorrhagic fevers including Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever remain critical threats, especially in regions with limited health-care capacity. Concurrently, antimicrobial resistance, the emergence of Candida auris, and the climate-driven expansion of endemic mycoses involving Histoplasma, Coccidioides, and Blastomyces highlight the increasing importance of fungal pathogens. Parasitic diseases such as artemisinin-resistant malaria, zoonotic trypanosomiasis, and expanding Leishmania transmission reflect shifting ecological conditions. These patterns are shaped by intersecting drivers including deforestation, wildlife trade, agricultural intensification, urban crowding, conflict, and rapid microbial evolution that enable spillover and sustained transmission. Although advances in genomic surveillance, metagenomic diagnostics, mRNA vaccines, monoclonal antibodies, and broad-spectrum antivirals have strengthened global response capacity, substantial gaps persist in equity, surveillance, and access to countermeasures. Strengthening One Health systems and resilient public health infrastructures is essential to anticipate and mitigate emerging infectious threats.

Concepts Keywords
Coronaviruses Animals
Decades Bird Flu
Deforestation Communicable Diseases, Emerging
Modern Coronavirus Infections
Zoonotic COVID-19
COVID-19
Emerging infectious diseases
Global health preparedness
H5N1
History, 21st Century
Humans
Influenza, Human
Novel coronaviruses
One health
Pandemic influenza
Pandemics
SARS-CoV-2
Zoonotic spillover

Semantics

Type Source Name
disease MESH influenza
disease MESH emerging infectious diseases
disease MESH AIDS
disease MESH smallpox
disease MESH avian influenza
disease MESH dengue
disease MESH yellow fever
disease MESH Viral hemorrhagic fevers
disease MESH Crimean-Congo hemorrhagic fever
disease MESH mycoses
disease MESH Parasitic diseases
drug DRUGBANK Artemisinin
disease MESH malaria
pathway KEGG Malaria
disease MESH trypanosomiasis
disease MESH Coronavirus Infections
disease MESH COVID-19
disease MESH Zoonotic spillover

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *